Avicanna Inc (AVCN) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.075x

Based on the latest financial reports, Avicanna Inc (AVCN) has a cash flow conversion efficiency ratio of -0.075x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-956.36K ≈ $-691.82K USD) by net assets (CA$12.79 Million ≈ $9.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AVCN days of operational coverage to measure how many days the company can operate on defensive assets alone.

Avicanna Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Avicanna Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Avicanna Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Avicanna Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
WIN Metals Ltd
AU:WIN
-0.183x
OSR Holdings Inc
NASDAQ:OSRH
-0.008x
Gold By Gold
PA:ALGLD
0.083x
PZ Cormay SA
WAR:CRM
-0.019x
Intraco Penta Tbk
JK:INTA
-0.008x
Elysee Development Corp
V:ELC
0.139x
exax Inc
KQ:060230
-0.030x
Carnegie Clean Energy Limited
F:CNM1
-0.027x

Annual Cash Flow Conversion Efficiency for Avicanna Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Avicanna Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Avicanna Inc worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$11.39 Million
≈ $8.24 Million
CA$-1.18 Million
≈ $-854.49K
-0.104x +60.32%
2024-12-31 CA$9.74 Million
≈ $7.05 Million
CA$-2.55 Million
≈ $-1.84 Million
-0.261x -48.44%
2023-12-31 CA$7.97 Million
≈ $5.77 Million
CA$-1.40 Million
≈ $-1.02 Million
-0.176x +91.81%
2022-12-31 CA$3.46 Million
≈ $2.50 Million
CA$-7.44 Million
≈ $-5.38 Million
-2.150x -27.33%
2021-12-31 CA$6.91 Million
≈ $5.00 Million
CA$-11.66 Million
≈ $-8.44 Million
-1.688x -68.10%
2020-12-31 CA$13.91 Million
≈ $10.06 Million
CA$-13.97 Million
≈ $-10.11 Million
-1.004x -54.28%
2019-12-31 CA$29.88 Million
≈ $21.61 Million
CA$-19.45 Million
≈ $-14.07 Million
-0.651x -244.11%
2018-12-31 CA$26.38 Million
≈ $19.08 Million
CA$-4.99 Million
≈ $-3.61 Million
-0.189x +92.54%
2017-12-31 CA$841.07K
≈ $608.42K
CA$-2.13 Million
≈ $-1.54 Million
-2.537x -506.93%
2016-12-31 CA$-29.76K
≈ $-21.53K
CA$-18.55K
≈ $-13.42K
0.623x --

About Avicanna Inc

TO:AVCN Canada Drug Manufacturers - Specialty & Generic
Market Cap
$12.74 Million
CA$17.61 Million CAD
Market Cap Rank
#26455 Global
#1079 in Canada
Share Price
CA$0.14
Change (1 day)
+12.00%
52-Week Range
CA$0.11 - CA$0.30
All Time High
CA$6.90
About

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios … Read more